Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2

International Immunology

Volumn 25, Issue 5, 2013, Pages 295-306

  Yasuda, Kei ^a   Nündel, Kerstin ^b   Watkins, Amanda A ^a   Dhawan, Tania ^a   Bonegio, Ramon G ^a   Ubellacker, Jessalyn M ^c   Marshak Rothstein, Ann ^b   Rifkin, Ian R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autoimmunity; Systemic lupus erythematosus; Type I IFN

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DEDICATOR OF CYTOKINESIS 2; GENOMIC DNA; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 6; PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; GENE MUTATION; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; DENDRITIC CELLS; GTPASE-ACTIVATING PROTEINS; INTERFERON REGULATORY FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PHENOTYPE;

EID: 84876783028     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs114     Document Type: Article

References (49)

1. Tamura, T., Yanai, H., Savitsky, D. and Taniguchi, T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535.
2. Paun, A. and Pitha, P. M. 2007. The IRF family, revisited. Biochimie 89:744.
3. Barnes, B. J., Moore, P. A. and Pitha, P. M. 2001. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276:23382.
4. Barnes, B. J., Kellum, M. J., Field, A. E. and Pitha, P. M. 2002. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell. Biol. 22:5721.
5. Takaoka, A., Yanai, H., Kondo, S. et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243.
6. Yasuda, K., Richez, C., Maciaszek, J. W. et al. 2007. Murine dendritic cell type I IFN production induced by human IgGRNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J. Immunol. 178:6876.
7. Yanai, H., Chen, H. M., Inuzuka, T. et al. 2007. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc. Natl. Acad. Sci. U.S.A. 104:3402.
8. Pandey, A. K., Yang, Y., Jiang, Z. et al. 2009. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5:e1000500.
9. Couzinet, A., Tamura, K., Chen, H. M. et al. 2008. A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105:2556.
10. Hu, G. and Barnes, B. J. 2009. IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. J. Biol. Chem. 284:2767
11. Sigurdsson, S., Nordmark, G., Göring, H. H. et al. 2005. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76:528.
12. Graham, R. R., Kozyrev, S. V., Baechler, E. C. et al.; Argentine and Spanish Collaborative Groups. 2006. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38:550.
13. Dieudé, P., Guedj, M., Wipff, J. et al. 2009. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum. 60:225.
14. Radstake, T. R., Gorlova, O., Rueda, B. et al.; Spanish Scleroderma Group. 2010. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat. Genet. 42:426.
15. Miceli-Richard, C., Comets, E., Loiseau, P., Puechal, X., Hachulla, E. and Mariette, X. 2007. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome. Arthritis Rheum. 56:3989.
16. Anderson, C. A., Boucher, G., Lees, C. W. et al. 2011. Metaanalysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43:246.
17. Dieguez-Gonzalez, R., Calaza, M., Perez-Pampin, E. et al. 2008. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum. 58:1264.
18. Stahl, E. A., Raychaudhuri, S., Remmers, E. F. et al.; BIRAC Consortium; YEAR Consortium. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42:508.
19. Cunninghame Graham, D. S., Manku, H., Wagner, S. et al. 2007. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum. Mol. Genet. 16:579.
20. Graham, R. R., Kyogoku, C., Sigurdsson, S. et al. 2007. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. U.S.A. 104:6758.
21. Ferreiro-Neira, I., Calaza, M., Alonso-Perez, E. et al. 2007. Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun. 8:429.
22. Marshak-Rothstein, A. and Rifkin, I. R. 2007. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25:419.
23. Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A. and Shlomchik, M. J. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417.
24. Pisitkun, P., Deane, J. A., Difilippantonio, M. J., Tarasenko, T., Satterthwaite, A. B. and Bolland, S. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669.
25. Deane, J. A., Pisitkun, P., Barrett, R. S. et al. 2007. Control of tolllike receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27:801.
26. Liu, Z. and Davidson, A. 2012. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat. Med. 18:871.
27. Richez, C., Yasuda, K., Bonegio, R. G. et al. 2010. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. J. Immunol. 184:796.
28. Tada, Y., Kondo, S., Aoki, S. et al. 2011. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum. 63:738.
29. Xu, Y., Lee, P. Y., Li, Y. et al. 2012. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus. J. Immunol. 188:4113.
30. Feng, D., Yang, L., Bi, X., Stone, R. C., Patel, P. and Barnes, B. J. 2012. Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Eur. J. Immunol. 42:1477.
31. Purtha, W. E., Swiecki, M., Colonna, M., Diamond, M. S. and Bhattacharya, D. 2012. Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses. Proc. Natl. Acad. Sci. U.S.A. 109:E898.
32. Fukui, Y., Hashimoto, O., Sanui, T. et al. 2001. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 412:826.
33. Nishikimi, A., Fukuhara, H., Su, W. et al. 2009. Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis. Science 324:384.
34. Tanaka, Y., Hamano, S., Gotoh, K. et al. 2007. T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2. Nat. Immunol. 8:1067.
35. Gotoh, K., Tanaka, Y., Nishikimi, A. et al. 2010. Selective control of type I IFN induction by the Rac activator DOCK2 during TLRmediated plasmacytoid dendritic cell activation. J. Exp. Med. 207:721.
36. Shi, G. P., Villadangos, J. A., Dranoff, G. et al. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10:197.
37. Hardy, R. R. and Hayakawa, K. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595.
38. Naik, S. H., Proietto, A. I., Wilson, N. S. et al. 2005. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174:6592.
39. Savitsky, D. A., Yanai, H., Tamura, T., Taniguchi, T. and Honda, K. 2010. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc. Natl. Acad. Sci. U.S.A. 107:10154.
40. Paun, A., Bankoti, R., Joshi, T., Pitha, P. M. and Stäger, S. 2011. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog. 7:e1001246.
41. Negishi, H., Ohba, Y., Yanai, H. et al. 2005. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. U.S.A. 102:15989.
42. Richez, C., Yasuda, K., Watkins, A. A. et al. 2009. TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming. J. Immunol. 182:820.
43. Lien, C., Fang, C. M., Huso, D., Livak, F., Lu, R. and Pitha, P. M. 2010. Critical role of IRF-5 in regulation of B-cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 107:4664.
44. Fang, C. M., Roy, S., Nielsen, E. et al. 2012. Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response. Genes Immun. 13:421.
45. Negishi, H., Yanai, H., Nakajima, A. et al. 2012. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat. Immunol. 13:659.
46. Krausgruber, T., Blazek, K., Smallie, T. et al. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12:231.
47. González-Navajas, J. M., Lee, J., David, M. and Raz, E. 2012. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12:125.
48. Kayagaki, N., Warming, S., Lamkanfi, M. et al. 2011. Noncanonical inflammasome activation targets caspase-11. Nature 479:117.
49. Kenneth, N. S., Younger, J. M., Hughes, E. D. et al. 2012. An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1. Biochem. J. 443:355.